Preventing infective complications relating to induced abortion.
Infective complications following induced abortions are still a common cause of morbidity and mortality. This review focusses on defining the strategies to improve care of women seeking an induced abortion and to reduce infective complications. We have considered the evidence for screening and cost-effectiveness for antibiotic prophylaxis. Current evidence suggests that treating all women with prophylactic antibiotics in preference to screening and treating is the most cost-effective way of reducing infective complications following induced abortions. The final strategy to prevent infective complications should be individualized for each region/area depending on the prevalence of organisms causing pelvic infections and the resources available.
Mary
Nirmala
N
New Royal Infirmary, Edinburgh, Midlothian, UK. nirmalamary@gmail.com
Mahmood
Tahir A
TA
D000028:Abortion, Induced / Q000009:adverse effects* / Q000379:methods; D000293:Adolescent; D000328:Adult; D019072:Antibiotic Prophylaxis / Q000191:economics / Q000379:methods*; D017963:Azithromycin / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004318:Doxycycline / Q000191:economics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008795:Metronidazole / Q000191:economics / Q000627:therapeutic use; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy / Q000209:etiology*; D011183:Postoperative Complications / Q000517:prevention & control; D011247:Pregnancy; D015231:Sexually Transmitted Diseases, Bacterial / Q000188:drug therapy; D055815:Young Adult
D008795:Metronidazole; D017963:Azithromycin; D004318:Doxycycline